The conundrum of estrogen receptor oscillatory activity in the search for an appropriate hormone replacement therapy

Endocrinology

Volumn 152, Issue 6, 2011, Pages 2256-2265

  Della Torre, Sara ^a   Biserni, Andrea ^b   Rando, Gianpaolo ^a   Monteleone, Giuseppina ^a   Ciana, Paolo ^a   Komm, Barry ^c   Maggi, Adriana ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Transgenic Operative Products srl   (Italy)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAZEDOXIFENE; CONJUGATED ESTROGEN; ESTROGEN; ESTROGEN RECEPTOR; LUCIFERASE; RALOXIFENE;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; HORMONE SUBSTITUTION; IN VIVO STUDY; METABOLIC REGULATION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; OSCILLATION; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; REPRODUCTION; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION;

ANIMALS; BONE AND BONES; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LIVER; MENOPAUSE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVARIECTOMY; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 79956327055     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2011-0173     Document Type: Article

References (44)

1. Mendelsohn ME, Karas RH 1999 The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811 (Pubitemid 29266405)
2. Bolego C, Vegeto E, Pinna C, Maggi A, Cignarella A 2006 Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease. Arterioscler Thromb Vasc Biol 26:2192-2199 (Pubitemid 44465711)
3. Straub RH 2007 The complex role of estrogens in inflammation. Endocr Rev 28:521-574 (Pubitemid 47236336)
4. Imai Y, Kondoh S, Kouzmenko A, Kato S 2009 Regulation of bone metabolism by nuclear receptors. Mol Cell Endocrinol 310:3-10
5. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB 2003 Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 290:1729-1738 (Pubitemid 37430623)
6. Sherwin BB 2003 Estrogen and cognitive functioning in women. Endocr Rev 24:133-151 (Pubitemid 36515282)
7. Maggi A, Ciana P, Belcredito S, Vegeto E 2004 Estrogens in the nervous system: mechanisms and nonreproductive functions. Annu Rev Physiol 66:291-313 (Pubitemid 40626712)
8. Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, Maggi A, Muramatsu M, Parker MG, Gustafsson JA 2006 International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 58:773-781
9. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S 2004 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291:1701-1712 (Pubitemid 38489892)
10. Turgeon JL, McDonnell DP, Martin KA, Wise PM 2004 Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304:1269-1273 (Pubitemid 38697412)
11. Johnson KA 2006 Editorial: the SERM of my dreams. J Clin Endocrinol Metab 91:3754-3756
12. Kharode Y, Bodine PV, Miller CP, Lyttle CR, Komm BS 2008 The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention. Endocrinology 149:6084-6091
13. Komm BS 2008 A new approach to menopausal therapy: the tissue selective estrogen complex. Reprod Sci 15:984-992
14. Ciana P, Raviscioni M, Mussi P, Vegeto E, Que I, Parker MG, Lowik C, Maggi A 2003 In vivo imaging of transcriptionally active estrogen receptors. Nat Med 9:82-86
15. Klotz DM, Hewitt SC, Ciana P, Raviscioni M, Lindzey JK, Foley J, Maggi A, DiAugustine RP, Korach KS 2002 Requirement of estrogen receptor-α in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor crosstalk. J Biol Chem 277:8531-8537 (Pubitemid 34968316)
16. Di Lorenzo D, Villa R, Biasiotto G, Belloli S, Ruggeri G, Albertini A, Apostoli P, Raviscioni M, Ciana P, Maggi A 2002 Isomer-specific activity of dichlorodyphenyltrichloroethane with estrogen receptor in adult and suckling estrogen reporter mice. Endocrinology 143:4544-4551 (Pubitemid 35397595)
17. Mussi P, Liao L, Park SE, Ciana P, Maggi A, Katzenellenbogen BS, Xu J, O'Malley BW 2006 Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland. Proc Natl Acad Sci USA 103:16716-16721 (Pubitemid 44737319)
18. Ciana P, Di Luccio G, Belcredito S, Pollio G, Vegeto E, Tatangelo L, Tiveron C, Maggi A 2001 Engineering of a mouse for the in vivo profiling of estrogen receptor activity. Mol Endocrinol 15:1104-1113 (Pubitemid 32618737)
19. Biserni A, Giannessi F, Sciarroni AF, Milazzo FM, Maggi A, Ciana P 2008 In vivo imaging reveals selective peroxisome proliferator activated receptor modulator activity of the synthetic ligand 3-[1-(4-chlorobenzyl)-3-t-butylthio- 5-isopropylindol-2-yl]-2,2-dimethylpro panoic acid (MK-886). Mol Pharmacol 73:1434-1443
20. Rando G, Biserni A, Ciana P, Maggi A 2010 Profiling of drug action using reporter mice and molecular imaging. Methods Mol Biol 602:79-92
21. Rando G, Casiraghi E, Arca S, Campadelli P, Maggi A Automatic segmentation of mouse images. In: Capasso V, et al., Stereology and image analysis. Proc 10th European Congress of ISS, Bologna (Italy), 2009, Esculapio, 60-64
22. Ciana P, Biserni A, Tatangelo L, Tiveron C, Sciarroni AF, Ottobrini L, Maggi A 2007 A novel peroxisome proliferator-activated receptor responsive element-luciferase reporter mouse reveals gender specificity of peroxisome proliferator-activated receptor activity in liver. Mol Endocrinol 21:388-400 (Pubitemid 46184892)
23. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2[-ΔΔC(T)] method. Methods 25:402-408 (Pubitemid 34164012)
24. Stossi F, Barnett DH, Frasor J, Komm B, Lyttle CR, Katzenellenbogen BS 2004 Transcriptional profiling of estrogen-regulated gene expression via estrogen receptor (ER) α or ERβ in human osteosarcoma cells: distinct and common target genes for these receptors. Endocrinology 145:3473-3486 (Pubitemid 38830020)
25. Krum SA, Miranda-Carboni GA, Lupien M, Eeckhoute J, Carroll JS, Brown M 2008 Unique ERα cistromes control cell type-specific gene regulation. Mol Endocrinol 22:2393-2406
26. Bland R 2000 Steroid hormone receptor expression and action in bone. Clin Sci (Lond) 98:217-240 (Pubitemid 30105532)
27. Peano BJ, Crabtree JS, Komm BS, Winneker RC, Harris HA 2009 Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland. Endocrinology 150:1897-1903
28. Vujovic N, Davidson AJ, Menaker M 2008 Sympathetic input modulates, but does not determine, phase of peripheral circadian oscillators. Am J Physiol Regul Integr Comp Physiol 295:R355-R360
29. Mahoney CE, Brewer D, Costello MK, Brewer JM, Bittman EL 2010 Lateralization of the central circadian pacemaker output: a test of neural control of peripheral oscillator phase. Am J Physiol Regul Integr Comp Physiol 299:R751-R761
30. Escobar C, Cailotto C, Angeles-Castellanos M, Delgado RS, Buijs RM 2009 Peripheral oscillators: the driving force for food-anticipatory activity. Eur J Neurosci 30:1665-1675
31. Métivier R, Penot G, Hübner MR, Reid G, Brand H, Kos M, Gannon F 2003 Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763 (Pubitemid 38030303)
32. Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, O'Malley BW, Mancini MA 2001 FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasome-dependent. Nat Cell Biol 3:15-23 (Pubitemid 32114827)
33. Lonard DM, Nawaz Z, Smith CL, O'Malley BW 2000 The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation. Mol Cell 5:939-948
34. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS 1992 Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89:4658-4662
35. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494
36. Coleman KM, Smith CL 2001 Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptors. Front Biosci 6:D1379-D1391
37. Walters MR, Dutertre M, Smith CL 2002 SKF-82958 is a subtype-selective estrogen receptor-α (ERα) agonist that induces functional interactions between ERα and AP-1. J Biol Chem 277:1669-1679 (Pubitemid 34975656)
38. Veeneman GH 2005 Non-steroidal subtype selective estrogens. Curr Med Chem 12:1077-1136 (Pubitemid 40674196)
39. Della Torre S, Rando G, Meda C, Stell A, Chambon P, Krust A, Ibarra C, Magni P, Ciana P, Maggi A 2011 Amino acid-dependent activation of liver estrogen receptor α integrates metabolic and reproductive functions via IGF-1. Cell Metab 13:205-214
40. Sismondi P, Biglia N, Ponzone R, Fuso L, Scafoglio C, Cicatiello L, Ravo M, Weisz A, Cimino D, Altobelli G, Friard O, De Bortoli M 2007 Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes. Maturitas 57:50-55 (Pubitemid 46602892)
41. Davis AM, Mao J, Naz B, Kohl JA, Rosenfeld CS 2008 Comparative effects of estradiol, methyl-piperidino-pyrazole, raloxifene, and ICI 182 780 on gene expression in the murine uterus. J Mol Endocrinol 41:205-217
42. Miki Y, Suzuki T, Nagasaki S, Hata S, Akahira J, Sasano H 2009 Comparative effects of raloxifene, tamoxifen and estradiol on human osteoblasts in vitro: estrogen receptor dependent or independent pathways of raloxifene. J Steroid Biochem Mol Biol 113:281-289
43. Chang KC, Wang Y, Bodine PV, Nagpal S, Komm BS 2010 Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens. J Steroid Biochem Mol Biol 118:117-124
44. Rando G, Horner D, Biserni A, Ramachandran B, Caruso D, Ciana P, Komm B, Maggi A 2010 An innovative method to classify SERMs based on the dynamics of estrogen receptor transcriptional activity in living animals. Mol Endocrinol 24:735-744